|
|
|
August 21, 2018
|
Fortune Top 100 Fastest-Growing Companies in 2018
Repligen: #74
|
Fortune Inc.
|
|
|
|
November 1, 2017
|
Purolite Selects Repligen's Market-Leading OPUS® Pre-Packed Columns
|
PR Newswire
|
October 3, 2017
|
Balancing the up and downstream: Repligen CEO talks R&D and M&A
|
Dan Stanton BioPharma Reporter
|
2017年6月23日
|
Repligen agrees to buy Spectrum for $359 milion
|
Robert Weisman Boston Globe
|
March 8, 2017
|
Repligen to up column production on back of 'milestone year of chromatography'
|
Dan Stanton BioPharma Reporter
|
|
|
|
December 20, 2016
|
Repligen adds single-use filtration technology through TangenX acquisition
|
Dan Stanton BioPharma Reporter
|
December 15, 2016
|
Repligen pays $40 milion to buy TangenX™ Technology
|
Robert Weisman Boston Globe
|
October 13, 2016
|
Repligen Launches Single-use Version of its Cell Retention Technology
|
Dan Stanton BioPharma Reporter
|
2016年5月11日
|
Special Report on Continuous Bioprocessing: Upstream, Downstream, ready for Prime Time?
|
Angelo DePalma, BioProcessing International
|
2016年5月10日 |
Repligen to expand chromatography column production capacity in US and Europe
|
Dan Stanton BioPharma Reporter |
April 12, 2016
|
Prepacked Chromatography Columns; Evaluation for Use in Pilot and Large-Scale Bioprecessing
|
Shaun Grier and Saani Yakubu BioProcess International
|
February 26, 2016
|
Repligen extends Protein A ligand supply deal with GE Healthcare
|
Dan Stanton BioPharma Reporter
|
January - February 2016
|
OPUS® Columns win Design Excellence Awards:
iF 2016 Design Excellence Award製品部門受賞
Winner - GOOD DESIGN 2015 Award for Design Excellence - Industry
Notable Mention - 2015 CORE77 Award for Design Excellence - Commercial Equipment
|
|
|
|
|
Fall 2015
|
WuXi Biologics Expands Perfusion Cell Culture Capabilities in 2016 using ATF 10 System
|
|
November 13, 2015
|
Announcing the 2014 North America Technology Fast 500™ Rankings: Annual ranking of fastest growing North America companies
|
Deloitte US
|
October 15, 2015
|
The Lowdown on Scale - Up Mismatches: Many of the Scale-Up Mismatches Can Be Avoided With Careful Planning
|
Angelo DePalma, Ph.D. Genetic Engineering News
|
September 1, 2015
|
Repligen Now a Bioprocess Product Firm: One-Time Therapeutics Player bets Future on Working as Supplier to Bioprocess Companies
|
Gail Dutton Genetic Engineering News
|
April 17, 2015
|
Repligen Boasts about the Size of Its Column
|
Dan Stanton BioPharma Reporter
|
April 1, 2015
|
Continuous Processing: A Changing Processing Paradigm
|
Randi Hernandez BioPharm International
|